NT_1170x120_1-11-18

drug pricing

PCMA’s Merritt issues statement on drug pricing

PCMA’s Merritt issues statement on drug pricing

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer Mark Merritt released the following statement on reports of yet another round of massive price hikes by drug manufacturers. “News of recent price increases by drugmakers further confirms that the easiest way to lower costs would be for drug companies to lower their prices.” This

NACDS issues memo to chain members on administration’s drug pricing policies

NACDS issues memo to chain members on administration’s drug pricing policies

ARLINGTON, Va. — NACDS today sent the following memo to chain members: We are writing to update you on President Trump’s announcement today regarding prescription drug pricing policies, and anticipated future events related to it. In short, we anticipate learning more details in the coming days, and NACDS will analyze the Administration’s proposals and provide

Congressman learns about Rx market

Congressman learns about Rx market

GREAT NECK, N.Y. — Rep. Tom Suozzi (D., N.Y.) got an education on drug cost dynamics during a tour of oncology pharmacy Onco360 here with members of the National Association of Specialty Pharmacy (NASP). Vice chairman of the Problem Solvers Caucus in the House of Representatives, Suozzi said he made the visit to learn more

Lawmaker seeks insight on drug cost dilemma

Lawmaker seeks insight on drug cost dilemma

No one claims to hold “the solution” to soaring costs for prescription drugs and how Americans and payers — including government — can afford to pay for them. But strides toward unraveling the tangle of problems behind this issue won’t be made without determined attempts at substantive discussion between the public and private sectors, according

Trump: ‘Drug industry has been disastrous’

Trump: ‘Drug industry has been disastrous’

Donald Trump briefly touched on the pharmaceutical industry in his first major press conference since being elected president. In the news conference yesterday at Trump Tower in Manhattan, Trump talked about drug companies relocating overseas and referred to the rising cost of pharmaceuticals. “We’ve got to get our drug industry back,” Trump said after discussing

What the Trump administration portends for pharmacy

What the Trump administration portends for pharmacy

The January 20, 2017, inauguration of President Trump as the nation’s 45th president is certain to bring with it changes in the health care environment, which may impact pharmacy in a variety of ways. As important as the new administration, however, is the fact that a “unified” government will take over in Washington, with Republicans

Trump, Clinton part ways on health care policy

Trump, Clinton part ways on health care policy

NEW YORK — With the 2016 presidential election drawing near, health care has emerged as a policy area in which the two major candidates’ differences are strikingly clear. A useful starting point might be their respective approaches to prescription drug pricing. The Republican candidate, Donald Trump, created a sensation in January when he advocated allowing